The U.S. Food and Drug Administration (FDA) has now made public information regarding import refusals for February 2018. Last month, the FDA reported that 3 out of the 156 (1.9%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics.
At the same time, the FDA revised its reporting of refusals for January to now omit reference to four entry lines of shrimp imported from Sea Fresh (Bangladesh) that were reported to have been refused by the Division of West Coast Imports on January 22, 2018 for nitrofurans. With the adjustments made by the FDA to its January reporting, there have been a total of four entry line refusals of shrimp for reasons related to banned antibiotics thus far this year: